Cargando…
FGF21 Is Associated with Metabolic Effects and Treatment Response in Depressed Bipolar II Disorder Patients Treated with Valproate
BACKGROUND: Patients with bipolar disorder are at high risk of metabolic disturbance after mood stabilizer treatment. However, the mediators linking the two conditions remain unknown. In this study, we investigated whether fibroblast growth factor-21 (FGF21) was associated with metabolic effects and...
Autores principales: | Chang, Hui Hua, Chen, Po See, Cheng, Yung Wen, Wang, Tzu-Yun, Yang, Yen Kuang, Lu, Ru-Band |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888470/ https://www.ncbi.nlm.nih.gov/pubmed/29618013 http://dx.doi.org/10.1093/ijnp/pyx093 |
Ejemplares similares
-
PS50. The serum oxytocin levels among major depressive and bipolar II disorder
por: Lien, Yueh-Ju, et al.
Publicado: (2016) -
Changes in striatal dopamine transporters in bipolar disorder and valproate treatment
por: Hsueh, Yuan-Shuo, et al.
Publicado: (2021) -
The aldehyde dehydrogenase 2 polymorphisms on neuropsychological performance in bipolar II disorder with or without comorbid anxiety disorder
por: Lu, Ru-Band, et al.
Publicado: (2018) -
Impairment in Emotional Intelligence May Be Mood-Dependent in Bipolar I and Bipolar II Disorders
por: Kuo, Shih-Yu, et al.
Publicado: (2021) -
Mitochondrial DNA Copy Number Is Associated With Treatment Response and Cognitive Function in Euthymic Bipolar Patients Receiving Valproate
por: Chang, Cheng-Chen, et al.
Publicado: (2022)